To support implementation of the recommendation on Medicines to Help Prevent Breast Cancer, the Task Force created a companion guide to facilitate meaningful discussions between healthcare providers and their patients. A two-page document, the first page outlines basic information about risk factors for breast cancer, the potential benefits and harms of risk-reducing medicines, and questions for patients to ask their healthcare providers. The second page provides additional information on assessing patient risk and more detailed data on benefits and harms.
Healthcare providers are encouraged to use this guide as a conversation starter with their patients. This guide is not intended to serve as a risk assessment tool or decision aid.
Medicines to Help Prevent Breast Cancer: Let's Talk About It (PDF File, 144 KB; PDF Help)